PFS Partners »

Trevi Therapeutics shares owned by PFS Partners

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by PFS Partners from 13F filings

Historical chart of PFS Partners investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by PFS Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by PFS Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $264k 79k 3.34
2024-06-30 $235k 79k 2.98
2024-03-31 $342k 99k 3.45
2023-12-31 $133k 99k 1.34
2023-09-30 $218k 100k 2.18
2023-06-30 $239k 100k 2.39

More positions owned by PFS Partners

Innovator Etfs Trust Us Sml Cp Pwr B (KJAN)
Ishares Tr Core Div Grwth (DGRO)
First Tr Exch Traded Fd Iii Shrt Dur Mng Mun (FSMB)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (XMAR)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Innovator Etfs Trust Intrnl Dev Aprl (IAPR)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low (XMLV)
American Intl Group Com New (AIG)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Select Sector Spdr Tr Financial (XLF)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr Core S&p500 Etf (IVV)
First Tr Exchange-traded Ft Vest S&p 500 (KNG)

View all positions for PFS Partners

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Rubric Capital Management
Viking Global Investors
VR Adviser
BlackRock
BlackRock
Logos Global Management
Opaleye Management
Vanguard Group
MPM Oncology Impact Management
MAI Wealth Advisors
Geode Capital Management
State Street Corporation
Silverarc Capital Management

View all funds holding Trevi Therapeutics